Yahoo India Web Search

Sign In

Search results

  1. www.genmab.comHome | Genmab

    Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases

  2. en.wikipedia.org › wiki › GenmabGenmab - Wikipedia

    Genmab was founded as a European spin-off of American Biotech company Medarex in February 1999. Danish investment firm BankInvest, under Florian Schönharting, provided the seed investment for the company to start up in Copenhagen. Like Medarex, Genmab began work producing monoclonal antibodies for life-threatening or debilitating diseases.

  3. www.genmab.com › aboutAbout | Genmab

    Discover Genmab, an international biotechnology company that creates,develops and commercializes and commercializes antibody therapeutics to treat cancer and other serious diseases.

  4. www.genmab.com › antibody-science › pipelinePipeline | Genmab

    May 29, 2024 · Genmab's antibody-based therapeutics have the potential to transform the treatment of cancer and other serious diseases. Explore our investigational medicines pipeline.

  5. www.us.genmab.comTransforming the Future of Antibody-Based Cancer Treatment | ...

    Genmab is a biotech company that creates antibody-based treatments for cancer and other serious diseases. Learn about our latest FDA approval. Read the Press Release

  6. www.linkedin.com › company › genmabGenmab | LinkedIn

    Genmab | 100,464 followers on LinkedIn. We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody...

  7. in.linkedin.com › company › genmabGenmab | LinkedIn

    To help develop and deliver novel antibody therapies to patients, we have formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, our vision is to transform the...

  8. ir.genmab.com › news-releases › news-release-detailsGenmab and AbbVie Announce Broad Oncology Collaboration

    Jun 10, 2020 · Genmab and AbbVie entered into a broad collaboration to jointly develop and commercialize three of Genmab’s next-generation bispecific antibody products, including epcoritamab; Companies establish a discovery research collaboration to create additional differentiated antibody therapeutics for cancer

  9. ir.genmab.com › news-releases › news-release-detailsGenmab to Broaden and Strengthen Oncology Portfolio with...

    Apr 3, 2024 · The addition of Rina-S to Genmab’s portfolio will enable Genmab to deepen its presence in the gynecologic oncology space and establish a firm foundation in solid tumors. As a potential best-in-class ADC, Rina-S aims to address a broader patient population than first-generation FRα-targeted ADCs.

  10. finance.yahoo.com › quote › GMABGenmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo...

    Find the latest Genmab A/S (GMAB) stock quote, history, news and other vital information to help you with your stock trading and investing.